Jump to section
To catalyze healthcare's greatest inventors by maximizing the value of patient insights - so that they can build up, not around.
131% employee growth in 12 months
Whilst the healthtech sector is growing fast, the kind of tech needed to build within each healthcare field can be radically different. The result has been that most of these companies develop in a vacuum, with time and resources wasted on unnecessary duplications of tools, data, and backends. Zus is looking to remedy this health data isolation issue by building a shared development platform for healthcare startups.
The idea is that companies will benefit from shared data in the backend - thus bringing down the cost and delays currently involved in setting up individual new companies. Whilst the healthtech boom of recent years is showing signs of abating, at least in the US, it’s still a strong and fertile market with plenty of room for innovation. This should keep interest high for capabilities like those offered by Zus.
Moreover, the company is led by HealthTech veteran Jonathan Bush. His tenure at athenahealth saw it ultimately sold in a $17B private equity deal after becoming a leading healthcare network service provider. With this expertise, a market-accelerating proposition, and impressive partnerships, Zus is becoming an important player.
Freddie
Company Specialist at Welcome to the Jungle
Mar 2023
$40m
EARLY VC
Jun 2021
$34m
SERIES A
This company has top investors
Jonathan Bush
(CEO)Originally an army medic, before consulting for a spell and then taking up an MBA at Harvard Business School. Subsequently founded athenahealth, and spent over two decades at the helm as CEO.
Software Engineering
Sales & Account Management